What is the waiver impact on innovation and pandemic preparedness?

Health Conversation

English - December 12, 2022 12:13 - 13 minutes - 31.5 MB - ★★★★★ - 1 rating
Medicine Health & Fitness Alternative Health health covid-19 r&d patients vaccines pharmaceutical pharma pharmaceutical industry research & development patient safety Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Why is a therapeutics waiver extension different to the vaccine waiver?

Next Episode: How can we navigate COVID-19 in a new winter health landscape?

Welcome to Health Conversation. Today we're asking Claire Skentelbery, Director General of EuropaBio, 'What is the waiver impact on innovation and pandemic preparedness?'. Listen to hear their discussion on the challenge and how we're preparing for the future.

Hosted on Acast. See acast.com/privacy for more information.